Effect of a non biologic treat-totarget strategy on MRI-determined inflammatory and destructive changes in early rheumatoid arthritis. Results from af 2-year investigator-initiated double-blind randomized controlled clinical trial.

Signe Møller-Bisgaard, Bo Jannik Ejbjerg, Iris Eshed, Kim Hørslev-Petersen, Merete Lund Hetland, Anne Grethe Jurik, Jørgen Vallø, Henrik Thomsen, Trine Torfing, Kristian Stengaard-Pedersen, Peter Junker, Niels Steen Krogh, Tine Lottenburger, Torkell Ellingsen, Lis Smedegaard Andersen, Ib Hansen, Henrik Skjødt, Anders Jørgen Svendsen, Ulrik Tarp, Jan PødenphantJens Kristian Pedersen, Hanne Merete Lindegaard, Mikkel Ostergaard

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdato2015
StatusUdgivet - 2015
BegivenhedACR/ARHP: American College of Rheumatology - San Francisco, USA
Varighed: 7. nov. 201511. nov. 2015

Konference

KonferenceACR/ARHP
Land/OmrådeUSA
BySan Francisco
Periode07/11/201511/11/2015

Citationsformater